Answer
Myopathy and rhabdomyolysis have been reported with raltegravir; caution is advised in patients with a history of either condition or predisposing factors, including other medicines associated with these conditions.
Sources for this answer
- Raltegravir 600 mg film-coated tabletsLupin Healthcare (UK) Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 1Document updated
Sources checked